Over recent years, Peter Mac has maintained a substantial portfolio of CAR-T and cellular immunotherapy clinical trials, including industry sponsored and investigator initiated. From July 2020 (and during COVID) a maximum eight CAR-T clinical trials have been running at any time, including both...

CAR-T therapy is a once-off, personalised treatment that uses a patient’s own reprogrammed T-cells to fight their cancer.

The Centre of Excellence in Cellular Immunotherapy was established at the Peter Mac to collaboratively discover, develop and deliver globally competitive breakthroughs in CAR-T and other cellular immunotherapies for the treatment of cancer.